Total Count 250

SPIMACO - Latest News

13/08/2025
SPIMACO updates 2025 guidance
Argaam Special
05/08/2025
SPIMACO CFO says private sector, expansions to drive Q3 growth
Argaam
27/07/2025
SPIMACO inaugurates oncology, high-potent drug plant
Argaam
14/07/2025
Morgan Stanley 'market maker' for 40 TASI, Nomu firms
Argaam
06/07/2025
United Securities issues Q2 2025 earnings forecast
Argaam
03/07/2025
Al Rajhi Capital issues earnings estimates for Q2 2025
Argaam
30/06/2025
SPIMACO shareholders OK dividend freeze for 2024
Argaam
28/05/2025
SPIMACO updates 2025 guidance
Argaam Special
15/05/2025
SPIMACO's market share hits 12.1%, positive performance to sustain: CFO
Argaam Special
14/04/2025
Al Rajhi Capital issues Q1 2025 profit forecasts for TASI-listed firms
Argaam
08/04/2025
SPIMACO appoints Khalid Al-Gwaiz as Chairman, Ahmed Aljedai as Vice Chairman
Argaam
27/03/2025
SPIMACO board proposes dividend freeze for 2024
Argaam
27/03/2025
SPIMACO signs deal with China’s CNBG to supply, manufacture vaccines
Argaam
26/03/2025
SPIMACO signs agreement with CanSinoBIO to supply vaccines
Argaam
27/02/2025
SPIMACO elects board members for upcoming term
Argaam
17/02/2025
What do analysts expect from SPIMACO’s Q4 2024 results?
Argaam Special
12/02/2025
SPIMACO CEO agrees to retain post for 6 additional months
Argaam
29/01/2025
SPIMACO shareholders to elect board members on Feb. 26
Argaam
19/01/2025
SPIMACO inks sale, distribution contract for SAR 164.1M annually
ِArgaam
09/01/2025
United Securities issues Q4 2024 earnings forecasts
Argaam
02/01/2025
Al Rajhi Capital issues Q4 2024 profit forecasts for TASI-listed firms
Argaam Special
25/12/2024
SPIMACO obtains SAR 220M credit facilities from Alinma Bank
Argaam
24/12/2024
Alawwal Capital initiates coverage on SPIMACO
Argaam
23/12/2024
SPIMACO reviews 2024 guidance
Argaam Special
04/12/2024
SPIMACO says deal to buy 68% of Osmopharm, exit SPIMACO Misr scrapped
ِArgaam
24/11/2024
United Securities says SPIMACO’s Q3 2024 topline below estimate, lowers TP
Argaam
24/11/2024
SPIMACO approves CEO request not to renew contract
Argaam
14/11/2024
SPIMACO extends deadline to buy 68% of Osmopharm, exit SPIMACO Misr
Argaam
31/10/2024
Analyst forecasts for SPIMACO's Q3 2024 financials
Argaam Special
07/10/2024
Al Rajhi Capital issues Q3 2024 earnings forecasts for more Tadawul-listed firms
Argaam
06/10/2024
United Securities: As earnings loom, what to expect in Q3 2024?
Argaam
09/09/2024
Saudi pharmaceuticals sector seen to grow: Al Rajhi Capital
ِArgaam
02/09/2024
Board member, senior exec ownership changes in Tadawul on Aug. 28
Argaam Special
21/08/2024
United Securities assigns rating, TP for SPIMACO
Argaam
19/08/2024
SPIMACO holds 6% of market, seeks 12% revenue growth
Argaam Special
31/07/2024
SPIMACO, Altos Biologics sign deal to produce, market ALT-L9 in 16 key markets
Argaam
28/07/2024
What analysts expect from SPIMACO Q2 2024 results?
Argaam Special
16/07/2024
United Securities issues Q2 earnings estimates
Argaam
04/07/2024
Al Rajhi Capital issues Q2 2024 profit forecasts
Argaam
13/06/2024
SPIMACO plans to appoint new external auditor
Argaam
08/05/2024
SPIMACO net profit expected to rise in Q1 2024
Argaam Special
21/04/2024
SPIMACO committed to expansion of complex products, focuses on African markets: CEO
Argaam
21/04/2024
Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023
Argaam Special
16/04/2024
Highest-paid executives, board members of Saudi-listed firms in 2023
Argaam Special
06/04/2024
Al Rajhi Capital issues Q1 profit forecasts for TASI-listed firms
Argaam
04/04/2024
SPIMACO continues deleveraging with robust financial position: CEO
Argaam
31/03/2024
SPIMACO board proposes to withhold 2023 dividends
Argaam
21/02/2024
SPIMACO appoints Jérôme Cabannes as CEO
Argaam
20/02/2024
SPIMACO losses likely to shrink in Q4 2023
Argaam Special
23/01/2024
SPIMACO signs term sheet to supply HPV vaccines
Argaam
08/01/2024
Al Rajhi Capital issues Q4 2023 earnings forecasts
Argaam Special
07/01/2024
United Securities previews Q4 2023 earnings for Saudi firms
Argaam Special
17/12/2023
SPIMACO completes full acquisition of Dammam Pharma
Argaam
23/11/2023
Al Rajhi Capital says Saudi pharmaceuticals sector poised for growth; sets recommendations, TP
Argaam
19/11/2023
SPIMACO’s subsidiary seals deal with Merck to manufacture type 2 diabetes meds in KSA
Argaam
15/11/2023
SPIMACO to transfer SAR 184.7 mln from reserves to offset accumulated losses
Argaam
14/11/2023
SPIMACO inks SPAs to acquire 68% of Osmopharm, divests 76.4% of SPIMACO Misr
Argaam
09/11/2023
SPIMACO Chairman resigns; Al-Jedai takes over
Argaam
23/10/2023
SPIMACO EGM to vote on SAR 185 mln reserve transfer to scrap accumulated losses on Nov. 14
Argaam
05/10/2023
Al Rajhi Capital issues Q3 profit forecasts for Saudi-listed companies
Argaam Special
01/10/2023
SPIMACO names Jerome Cabannes as Acting CEO
Argaam
24/09/2023
Senior execs underscore Saudi achievements
Argaam Special
11/08/2023
MSCI adds 8 Saudi firms in periodic review
Argaam
10/07/2023
Al Rajhi Capital issues Q2 earnings estimates
ِArgaam
05/07/2023
Al Rajhi Capital begins coverage of Saudi pharma sector, assigns ratings
Argaam
14/06/2023
SPIMACO secures SAR 300 mln credit facility from BSF
Argaam
11/06/2023
SPIMACO board proposes 815,000 share buyback for LTIP
Argaam
17/05/2023
Better sales, productivity boosted Q1 revenue: SPIMACO
Argaam Special
12/05/2023
MSCI adds 3 Saudi firms in quarterly review
Argaam
29/03/2023
SPIMACO board recommends no dividend for 2022
Argaam
28/02/2023
These 36 Tadawul-listed firms likely to announce dividends in March
Argaam Special
16/02/2023
SPIMACO's target investments in new projects at SAR 2.5 bln: CEO
Argaam Special
07/02/2023
SPIMACO to hold virtual capital markets day to outline revamped 5-year plan today
Argaam
29/12/2022
SPIMACO signs SAR 900 mln credit facilities with SABB, Al Rajhi Bank
Argaam
25/12/2022
SPIMACO finalizes permits to occupy Riyadh administrative tower
Argaam
19/12/2022
SPIMACO set to launch revamped 5-year plan
Argaam
01/12/2022
SABIC signs MoU with SPIMACO to develop Kingdom’s active pharmaceutical ingredient industry
ِArgaam
30/11/2022
MSCI implements periodic changes to Saudi market today
Argaam Special
17/11/2022
Qassim Governor launches SAR 272 mln SPIMACO-AstraZeneca factory
Argaam
11/11/2022
MSCI adds 12 firms to MSCI Saudi Arabia Standard Index in semi-annual review
Argaam
20/09/2022
SPIMACO signs SAR 135 mln contract for license, supply, co-marketing of 2 products
Argaam
15/09/2022
FTSE Russell implements semi-annual review of Saudi Arabia Free Index today
Argaam
01/09/2022
FTSE Russell announces semi-annual review of Saudi Arabia Free Index
Argaam
31/08/2022
MSCI implements periodic changes to Saudi constituents in index review today
Argaam Special
29/08/2022
SPIMACO signs credit facilities with 3 banks for SAR 1.26 bln
Argaam
12/08/2022
MSCI keeps Saudi firms unchanged in MSCI Saudi Arabia Standard Index
Argaam
08/06/2022
Tadawul: 3 firms go ex-dividend, 1 ex-rights today
Argaam
16/05/2022
SPIMACO shareholders to vote on 6% cash dividend for 2021 on June 8
Argaam
18/04/2022
Key events likely to impact Saudi-listed firms’ earnings in Q1 2022
Argaam Special
04/04/2022
SPIMACO reappoints Mohammed Al-Nahas as Chairman
Argaam
24/03/2022
SPIMACO board plans 6% cash dividend for 2021
Argaam
01/03/2022
Tadawul-listed firms likely to reveal dividends in March
Argaam Special
28/02/2022
MSCI implements periodic changes to Saudi constituents in index review today
Argaam Special
24/02/2022
SPIMACO shareholders elect board members for upcoming term
Argaam
17/02/2022
SPIMACO shareholders to start e-voting on OGM agenda on Feb. 19
Argaam
10/02/2022
MSCI adds SRMG to MSCI Saudi Arabia Standard Index in quarterly review
Argaam
01/02/2022
SPIMACO shareholders to vote on electing board members on Feb. 23
Argaam
17/01/2022
SPIMACO signs SAR 240 mln deal with Swiss firm to localize injection manufacturing
Argaam
03/01/2022
Top projects, expansions expected to be launched by Tadawul-listed firms in 2022
Argaam Special
30/11/2021
SPIMACO opens board membership nominations today
Argaam

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2025, Argaam Investment, All Rights Reserved
Call Request